- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07288086
Betrouwbaarheid en effectiviteit van het nieuwe Enova voorgevulde intraoculaire lens- en cartridge-systeem
Evaluation of the safety and efficacy of the new Enova® preloaded monofocal intraocular lens and cartridge injector system in cataract surgery
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
In this prospective and single-center clinical study, the safety and efficacy of the Enova PGF3 intraocular lens (IOL) and cartridge injector system will be evaluated.
The Enova PGF3 cartridge injector system is designed to be used in cataract surgeries. Cataract patients aged 40 years and older, both male and female, without any serious ocular disease other than cataracts, will undergo IOL implantation following cataract surgery. It is planned to perform a total of 200 implantations with either unilateral or bilateral implantation of the participants' eyes.
Postoperative visual acuity, refraction, patient satisfaction, and adverse events will be monitored during follow-up visits at day 1, week 1, and month 1.
The primary objectives of the study are to achieve an uncorrected distance visual acuity of 20/20 or better, and to maintain an error and complication rate related to the preloaded system below 7.5%. Secondary objectives include evaluating patient satisfaction and assessing whether surgeons find the preloaded system easy to use and if it meets their expectations.
The primary endpoints are refractive stability within ±0.50 D, uncorrected distance visual acuity of 20/20 or better, and a general clinical performance rating of the preloaded system with a score of 95% or higher. Secondary endpoints include the duration of surgery, accuracy of lens positioning, surgical complications, surgeon-reported ease of use, and patient satisfaction survey results meeting expectations.
As a safety parameter, adverse events reported in postoperative surgical reports will be evaluated.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Fatih
-
Istanbul, Fatih, Turkije (Türkiye), 34250
- Istanbul University Istanbul Medical Faculty Ophthalmology Department
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Adults of either sex.
Age 40 years or older.
Willing and able to provide written informed consent and comply with planned study visits and procedures.
Healthy ocular status, with no ocular pathology other than cataract and mild refractive error.
Potential visual acuity of 20/32 (0.2 logMAR) or better in both eyes.
Presence of regular corneal astigmatism suitable for treatment with the study device.
Candidates for uncomplicated cataract surgery using the study device.
Exclusion Criteria:
- Irregular corneal astigmatism (e.g., keratoconus).
Corneal pathology (e.g., scar, dystrophy, pterygium, moderate to severe dry eye).
Monocular conditions (e.g., amblyopia).
Previous corneal surgery, including radial keratotomy, corneal refractive surgery, corneal transplantation, DSAEK, or lamellar keratoplasty.
Previous anterior or posterior segment surgery (e.g., vitrectomy, laser iridotomy).
Diabetic retinopathy.
Macular pathology (e.g., age-related macular degeneration [ARMD], epiretinal membrane [ERM]).
History of retinal detachment.
Surgical complications that may affect study outcomes, such as:
Decentration due to capsulorhexis issues
Improper lens placement
Inadequate or missing postoperative capsular support
Posterior capsular rupture
Vitreous loss
Iris damage (tear, rupture, etc.)
Acute or chronic ocular diseases known to affect visual acuity or study outcomes (e.g., immunosuppressed state, connective tissue disease, clinically significant atopic disease, diabetes, or other systemic or ocular conditions).
Participation in any investigational drug or device study within 30 days prior to study start, or ongoing participation in another study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Patients who need cataract surgery
Participants will undergo standard cataract surgery using the new preloaded intraocular lens (IOL) system. The intervention involves implantation of the preloaded IOL following routine phacoemulsification techniques. |
This intervention uses a preloaded IOL delivery system, which allows for a single-use, sterile implantation during standard phacoemulsification cataract surgery. Unlike standard manually loaded IOLs, this system reduces preparation time and minimizes handling of the lens, potentially improving surgical efficiency and maintaining lens sterility. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Uncorrected Distance Visual Acuity (UDVA) - Photopic Conditions
Tijdsspanne: 1 month postoperatively
|
Proportion of eyes achieving 20/20 or better uncorrected distance visual acuity under photopic conditions. |
1 month postoperatively
|
|
Subjective Refractive Error
Tijdsspanne: 1 month postoperatively
|
Eyes with a postoperative refractive error within ±0.50 diopters of the intended target. |
1 month postoperatively
|
|
Overall Clinical Performance of the Preloaded IOL System
Tijdsspanne: 1 month after surgery
|
Surgeon-rated assessment of the general clinical performance of the preloaded system by The ENOVA PGF3 Questionnaire. This questionnaire is a 14-item, study-specific, non-validated survey developed to evaluate surgeons' experience with an intraocular lens (IOL) preloaded delivery system. Eleven items are rated on a 5-point Likert scale with the following scoring structure:
Some additional items are Yes/No questions and do not contribute to the numerical total score. The total numerical score is calculated by summing the 11 Likert-scaled items. Total score range: 11 to 55, with higher scores indicating better performance and more favorable user experience. |
1 month after surgery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Preloaded System Evaluation Patient Questionnaire
Tijdsspanne: Baseline (preoperative) and 1 month postoperatively
|
Patient-reported outcomes assessing whether expectations for visual improvement and overall satisfaction were met.The questionnaire consists of 14 items assessing a patient's self-reported difficulty in performing vision-related daily activities. Each activity is rated using a 0-4 scale, where: 4 = No difficulty 3 = Mild difficulty 2 = Moderate difficulty 1 = Severe difficulty 0 = Unable to perform the activity The total score is calculated by summing responses across all 14 items. Total possible score range: 0 to 56 Higher scores indicate better visual function and less activity limitation. Lower scores indicate worse visual function. |
Baseline (preoperative) and 1 month postoperatively
|
|
Surgical Procedure Assessment
Tijdsspanne: Intraoperative
|
Surgeon-reported ease of lens implantation and accuracy of lens placement, evaluating whether expectations for procedural handling were met.The surgeon notes, during the operative visit, the location of the incision, the size of the incision, whether the implantation system is compatible with the wound site, how many seconds the implantation time is shortened, and whether there were any issues with the unfolding of the intraocular lens or its placement into the capsular bag. |
Intraoperative
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Serious Adverse Events
Tijdsspanne: 1 month postoperatively
|
Any serious adverse events occurring during surgery or within 1 month after surgery. |
1 month postoperatively
|
|
Postoperative Inflammation
Tijdsspanne: 1 week and 1 month postoperatively
|
Assessment of inflammation levels by biomicroscopic anterior chamber and vitreus examination according to Standardization of Uveitis Nomenclature (SUN) International Workshop Grading System |
1 week and 1 month postoperatively
|
|
Intraocular Pressure,
Tijdsspanne: 1 week and 1 month postoperatively
|
Intraocular pressure is assessed via Goldmann Applanation Tonometry. Normal levels are accepted as 10-21 mmHG. |
1 week and 1 month postoperatively
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Oshika T, Wolfe P. In vitro comparison of delivery performance of 4 preloaded intraocular lens injector systems for corneal and sclerocorneal incisions. J Cataract Refract Surg. 2019 Jun;45(6):840-846. doi: 10.1016/j.jcrs.2018.10.050. Epub 2019 Mar 8.
- Joshi RS. Comparative evaluation of an automated preloaded delivery system with a non-preloaded system. Indian J Ophthalmol. 2022 Dec;70(12):4307-4311. doi: 10.4103/ijo.IJO_1635_22.
- Acar B, Torun IM, Acar S. Evaluation of Preloaded IOL Delivery System and Hydrophobic Acrylic Intraocular Lens in Cataract Surgery. Open Ophthalmol J. 2018 Jun 14;12:94-103. doi: 10.2174/1874364101812010094. eCollection 2018.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- IstanbulUni
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data will not be shared outside the study.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .